Advisory - One lot of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops recalled because of a packaging error that may pose health risks
Issue: Teva Canada Ltd. is recalling one lot of each product because of a packaging error that may pose health risks.
What to do: Do not use the affected product. Consult a health care professional if you have used this product and have health concerns.
Issue
Teva Canada Ltd. is recalling one lot each of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops because of a packaging error. Some bottles may contain ingredients that are not listed on the label and that may pose health risks to individuals who are allergic to the ingredients.
The products are used for the temporary relief of eye redness due to minor eye irritation, burning and dryness. They are labelled for use by adults and children 6 years of age and older.
Following a complaint involving the Pharmasave eye drops, the company identified that some bottles in one lot of both the Pharmasave and Compliments products may have been packaged with another eye-drop product that contains different active ingredients. Glycerine 0.25% and naphazoline HCl 0.012% were present in bottles which were labelled to contain Dextran 70 0.1%, Povidone 1%, Polyethylene glycol 400 1%, Tetrahydrozoline hydrochloride 0.05%.
Naphazoline HCl or glycerine may cause a reaction in individuals allergic to these ingredients. Signs of an allergic reaction include rash, and itching or swelling, especially of the face, tongue and throat.
Cartons of the affected Pharmasave and Compliments eye drops are labelled with lot number AR21C03. The affected bottles may be labelled with either lot number AR21C03 or RL21D01.
Health Canada is monitoring the company's recall and implementation of any necessary corrective and preventative actions. If additional safety information is identified, Health Canada will take appropriate action and inform Canadians as needed.
Affected products
Product
DIN
Lot
Expiry
Pharmasave Advanced Relief Eye Drops, 15 mL
02344319
AR21C03 (on cartons and some bottles) RL21D01 (on some bottles)
31 Mar 2024
Compliments Advanced Relief Eye Drops, 15 mL
02344319
AR21C03 (on cartons and some bottles)
RL21D01 (on some bottles)
31 Mar 2024
What you should do
Do not use the affected product. Consult a health care professional if you have used this product and have health concerns.
Contact Teva Canada Ltd. at Teva Canada Customer Care by calling 1-800-268-4129 if you have questions about the recall.
Children's HealthSM and UT Southwestern Medical Center announced a historic gift of $100 million from the Jean and Mack Pogue family in support of the $5 billion new Dallas pediatric campus, unveiled earlier this year. The gift from the Pogue...
Amgen will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE® in chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS)...
Baltimore Urban Gardening with Students (BUGS), a program operated by The Crossroads School, a Living Classrooms Foundation Charter School, is excited to announce its 26th Annual Youth Farmer's Market taking place on Saturday, May 18th, from 9:00 AM...
DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units...
A new guideline has been issued to help neurologists and other clinicians determine the best antiseizure medications for people with epilepsy who may become pregnant. The guideline is published in the May 15, 2024, online issue of Neurology®, the...
The leading cause of death worldwide is chronic inflammatory diseases. When the body is inflamed and under stress for long periods of time, the body's heart rate increases, increasing the risk of fatality. A new study published in Brain, Behavior and...